Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PYM-50028 can be delivered to patients with PD at preclinically efficacious doses

June 22, 2010

Memantine reduces "off" time in Parkinson's disease

June 22, 2010

Merck & Co. presents promising clinical data on MK-4827, MK-1775 and MK-0752

June 21, 2010

MIP-3-alpha level in serum functions as prognostic biomarker in colorectal cancer

June 21, 2010

Interim phase II data presented on vorinostat/gemtuzumab ozogamicin in AML

June 21, 2010

AFQ-056 reduces levodopa-induced dyskinesia in Parkinson's disease

June 21, 2010

CEP cells show promise as biomarker for response to antiangiogenic therapy in CRPC

June 18, 2010

AZD-6244 is beneficial in phase II trial in IRPTC and PTC

June 18, 2010

SRX-251 shows favorable safety, tolerability and pharmacokinetics in healthy subjects

June 18, 2010

Final phase II data on voreloxin/cytarabine in AML support phase III testing

June 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...